Skip to main content
. Author manuscript; available in PMC: 2020 Feb 19.
Published in final edited form as: J Am Coll Cardiol. 2019 Feb 19;73(6):643–651. doi: 10.1016/j.jacc.2018.10.086

Figure 1. Cumulative incidence of death with TEVAR and open surgical repair.

Figure 1.

The difference in mortality between open surgical repair and TEVAR was statistically significant by the log-rank test, p <0.001. Additionally, the difference in restricted mean survival time was significant: −209.2 days (95% CI −298.7 to −119.7 days; p <0.001) suggesting that there was a substantial survival disadvantage with open surgical repair.